Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Computerised tomogram, Laboratory test, Pain, Thrombosis
Clinical narrative: blood clot in my lungs/Multiple blood clots; Pains; This is a spontaneous report from a contactable consumer. This 69-year-old female consumer reported for herself that:  Patient characteristics: Weight (kg): 102.97 Height (cm): 165 Sex: Female  Relevant medical history and concurrent conditions:  Structured information (Patient episode name): Hypertension Patient Medical comments: Verbatim: Hypertension  Reaction(s)/Event(s): Reaction/event as reported by primary source: Blood clot in my lungs within the first 2 weeks after the second shot  Reaction(s)/Event(s): Reaction/event as reported by primary source: Hospitalization Reaction/event in MedDRA terminology (LLT): Hospitalization Reaction/event MedDRA term (PT): Hospitalisation  Reaction(s)/Event(s): Reaction/event as reported by primary source: Pains  Results of tests and procedures for investigation of the patient: Test: CTA scan More information available (Y/N): No  Drug(s) Information: Characterization of drug role: Suspect Proprietary medicinal product name: Covid-19 Vaccine Batch/lot number: ER8732 Date of start of drug: 30Mar2021 Action(s) taken with drug: Unknown  Drug(s) Information: Characterization of drug role: Concomitant Proprietary medicinal product name: Lisinopril HCTZ Dosage text: 20-25 mg Tablet Indication for use in the case: Hypertension  Narrative case summary and further information: Case narrative: Selected Report Type: Initial Patient Ethnicity: (Ethnicity withheld) Is the patient also the reporter? Yes Reporter type: Consumer or other non-health professional Reporter telephone: (Phone no withheld)  Primary / Prescribing Healthcare Professional Info   Dates for Blood clot in my lungs within the first 2 weeks after the second shot.: (From: Unspecified To: Unspecified) Dates for Hospitalization: (From: Unspecified To: Unspecified) Dates for Pains: (From: Unspecified To: Unspecified)  Is Covid-19 Vaccine a Pfizer product? Yes Covid-19 Vaccine manufacturer: Unspecified Dates for Covid-19 Vaccine: (Start: 30Mar2021 Stop: Unspecified) NDC number of Covid-19 Vaccine: Unknown UPC number of Covid-19 Vaccine: Unknown Expiry Date of Covid-19 Vaccine: 31Jul2021  Other Products: Yes Dates for Concomitant Products Lisinopril HCTZ: (Start: Unspecified Stop: Unspecified)  Patient History: Yes Patient history: Hypertension (From: Unspecified To: Unspecified) Investigation Assessment: Yes Investigation: CTA scan (Date: Unspecified, Result / Units: )  Additional Context: Consumer stated, "I could not follow on the parts. So may be should have done certainly but I am not technically astute. So, I wanted to report that I just had the second Covid-19 test and as a experience in  emergency room discovery of blood clot in my lungs within the first 2 weeks after that second shot. So, I wanted to report that. Is this the place I do that?"  When paraphrased, consumer stated, "Multiple blood clots."  Start date of event (Multiple blood clots.): Consumer stated, "10Apr2021. I should probably say that the pains were 09Apr. I went in the emergency room on the 10th. So, I am not sure which day."  Treatment :Consumer stated, "Yes, I went To the emergency room and was kept in the hospital and then I saw my own Doctor just today who is going to help me try to determine what is going to happen next ? I was released by the hospital."  Details of hospitalization:  Duration of hospitalization: 24 hrs. (overnight) Date of Admission:10Apr2021 Date of Discharge:11Apr2021  Lab work: Consumer stated, "They did lab. work while in the emergency room and in the hospital. They did Chest CTA scan."   This is a spontaneous report from a contactable consumer. A 69-year-old female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), via an unspecified route of administration on 30Mar2021 (Batch/Lot Number: ER8732; Expiration Date: 31Jul2021) as single dose for covid-19 immunisation at age of vaccination 69-year-old.  Medical history included hypertension from an unknown date. Concomitant medication included hydrochlorothiazide/lisinopril (LISINOPRIL HCTZ) taken for hypertension, start and stop date were not reported.  The patient experienced blood clot in my lungs/multiple blood clots (thrombosis) (hospitalization) on 10Apr2021 with outcome of unknown , pains (pain) (hospitalization) on 09Apr2021 with outcome of unknown.  The patient was hospitalized for blood clot in my lungs/multiple blood clots (thrombosis) from 10Apr2021 to 11Apr2021.  The patient was hospitalized for pains (pain) from 10Apr2021 to 11Apr2021.  The patient underwent lab tests and procedures which included computerised tomogram: unknown results   on     , laboratory test: unknown results   on    .  The action taken in response to the event(s) for bnt162b2 was not applicable.  Therapeutic measures were taken as a result of blood clot in my lungs/multiple blood clots (thrombosis), pains (pain).